Gastric intestinal metaplasia is associated with gastric dysplasia but is inversely correlated with esophageal dysplasia

Table 3 Associations among endoscopic findings (prior to or without histopathology) and gastric intestinal metaplasia

	Frequency in patients with gastric IM, n = 418	Frequency in patients without gastric IM, n = 171	Univariate analysis	Multivariate analysis (OR, 95%CI)
Gastritis	100 (23.9%)	37 (21.6%)	P = 0.557	1.34 (0.84, 2.08), P = 0.223
Atrophic gastritis	55 (13.2%)	9 (5.3%)	P = 0.004	2.05 (1.00, 4.58), P = 0.051
Gastric mass	20 (4.8%)	0 (0%)	P = 0.001	8.84 (1.88, ∞), P = 0.005
Gastric ulcer	42 (10.0%)	11 (6.4%)	P = 0.163	1.42 (0.71, 3.01), P = 0.339
Gastric nodularity	71 (17.0%)	33 (19.3%)	P = 0.503	0.74 (0.46, 1.20), P = 0.213
Linitis plastica	1 (0.2%)	0 (0%)	P = 0.710	0.27 (0.01, ∞), P = 0.788
Esophagitis	28 (6.7%)	23 (13.4%)	P = 0.011	0.49 (0.26, 0.91), P = 0.023
Esophageal mass	2 (0.5%)	13 (7.6%)	P < 0.001	0.04 (0.01-0.16), P < 0.001
Barrett’s esophagus	21 (5.0%)	13 (7.6%)	P = 0.235	0.56 (0.26, 1.21), P = 0.134
Duodenitis	17 (4.1%)	11 (6.4%)	P = 0.234	0.69 (0.30, 1.60), P = 0.337
Duodenal polyp	8 (1.9%)	0 (0%)	P = 0.063	4.21 (0.81, ∞), P = 0.081
Duodenal mass	4 (1.0%)	0 (0%)	P = 0.253	1.58 (0.26, ∞), P = 0.353
Duodenal ulcer	2 (0.5%)	2 (1.2%)	P = 0.407	0.21 (0.02, 2.20), P = 0.179

IM: Intestinal metaplasia.